Comparison of ox-LDL levels in diabetic patients with normo-, micro-, and macroalbuminuria with their first degree relatives and the healthy control group

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Behzadi, Parisa ^a   Torabi, Firouzeh ^a   Amini, Massoud ^b   Aminorroaya, Ashraf ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RELATIVE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84870189438     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/167154     Document Type: Article

References (21)

1. Yan M., Mehta J. L., Zhang W., Hu C., LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications. Cardiovascular Drugs and Therapy 2011 25 5 451 459 2-s2.0-84255163024 10.1007/s10557-011-6342-4
2. Gutwein P., Abdel-Bakky M. S., Doberstein K., Schramme A., Beckmann J., Schaefer L., Amann K., Doller A., Kämpfer-Kolb N., Abdel-Aziz A. A. H., El Sayed E. S. M., Pfeilschifter J., CXCL16 and oxLDL are induced in the onset of diabetic nephropathy. Journal of Cellular and Molecular Medicine 2009 13 9B 3809 3825 2-s2.0-77449083883 10.1111/j.1582-4934.2009.00761.x
3. Turk Z., Šesto M., Skodlar J., Ferenčak G., Turk N., Stavljenić-Rukavina A., Soluble LDL-immune complexes in type 2 diabetes and vascular disease. Hormone and Metabolic Research 2002 34 4 196 201 2-s2.0-0036100006 10.1055/s-2002-26706 (Pubitemid 34553533)
4. Tsuzura S., Ikeda Y., Suehiro T., Ota K., Osaki F., Arii K., Kumon Y., Hashimoto K., Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 2004 53 3 297 302 2-s2.0-1842454052 10.1016/j.metabol.2003. 10.009 (Pubitemid 38684688)
5. Girona J., Manzanares J. M., Marimón F., Cabré A., Heras M., Guardiola M., Ribalta J., Masana L., Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutrition, Metabolism and Cardiovascular Diseases 2008 18 5 380 387 2-s2.0-44449083290 10.1016/j.numecd.2007.04.002 (Pubitemid 351756531)
6. Mshelia D. S., Pindiga H. U., Review article: dyslipidaemia, lipid oxidation, and free radicals in diabetic nephropathy: an overview. Highland Medical Reaserch Journal 2004 2 1
7. Nomura S., Shouzu A., Omoto S., Nishikawa M., Iwasaka T., Fukuhara S., Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clinical and Applied Thrombosis/Hemostasis 2004 10 3 205 215 2-s2.0-3242809749 10.1177/107602960401000302 (Pubitemid 38982044)
8. Nosadini R., Tonolo G., Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 2 79 85 2-s2.0-79451472114 10.1016/j.numecd.2010.10.002
9. Abdelsamie S. A., Li Y., Huang Y., Lee M. H., Klein R. L., Virella G., Lopes-Virella M. F., Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III. Clinical Immunology 2011 139 3 258 266 2-s2.0-79955962025 10.1016/j.clim.2011.01.016
10. Quigg R. J., If oxidized LDL immune complexes are relevant in diabetic atherosclerosis, shouldn't they also be relevant in diabetic nephropathy? Clinical Immunology 2011 139 3 233 234 2-s2.0-79955957093 10.1016/j.clim.2011. 03.012
11. Ujihara N., Sakka Y., Takeda M., Hirayama M., Ishii A., Tomonaga O., Babazono T., Takahashi C., Yamashita K., Iwamoto Y., Association between plasma oxidized low-density lipoprotein and diabetic nephropathy. Diabetes Research and Clinical Practice 2002 58 2 109 114 2-s2.0-0036837047 10.1016/S0168-8227(02) 00134-1
12. American Diabetes Association, Diabetic nephropathy. Diabetes Care 2002 25 supplement 1 S86
13. Vaccaro O., Riccardi G., Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 2005 28 7 1786 1788 2-s2.0-21544432714 10.2337/diacare.28.7.1786 (Pubitemid 40923093)
14. Sesti G., Andreozzi F., Bonadonna R. C., De Mattia G., Leonetti F., Luzi L., Marini M. A., Natali A., Vettor R., Bonora E., Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database. Diabetes/Metabolism Research and Reviews 2008 24 2 130 136 2-s2.0-39649090315 10.1002/dmrr.775 (Pubitemid 351284757)
15. Kondo A., Manabe M., Saito K., Maekawa M., Kanno T., Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes. Journal of Atherosclerosis and Thrombosis 2002 9 6 280 287 2-s2.0-0141526100
16. Holvoet P., Vanhaecke J., Janssens S., Van De Werf F., Collen D., Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998 98 15 1487 1494 2-s2.0-0032514728 (Pubitemid 28481664)
17. Nakhjavani M., Esteghamati A., Khalilzadeh O., Asgarani F., Mansournia N., Abbasi M., Association of macroalbuminuria with oxidized LDL and TGF- β in type 2 diabetic patients: a case-control study. International Urology and Nephrology 2010 42 2 487 492 2-s2.0-77956181479 10.1007/s11255-009-9643-9
18. Atchley D., Lopes-Virella M., Zheng D., Kenny D., Virella G., Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia 2002 45 11 1562 1571 2-s2.0-0036435829 10.1007/s00125-002-0962-y (Pubitemid 35352050)
19. Moro E., Zambon C., Pianetti S., Cazzolato G., Pais M., Bittolo Bon G., Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation. Acta Diabetologica 1998 35 3 161 164 2-s2.0-0031762409
20. Lopes-Virella M. F., Carter R. E., Baker N. L., Lachin J., Virella G., High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes. Nephrology Dialysis Transplantation 2012 27 4 1416 1423 2-s2.0-84859336649 10.1093/ndt/gfr454
21. Rashidi A., Nakhjavani M., Esteghamati A., Asgarani F., Khalilzadeh O., Abbasi M., Safari R., Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients. Journal of Nephrology 2009 22 6 733 738 2-s2.0-72149091442